TAKEDA PHARMACEUTICALS U.S.A., INC.
Corporation · WILMINGTON, United States · LEI 549300W0D7WG0MRLHP67
LEI lapsed
Summary
TAKEDA PHARMACEUTICALS U.S.A., INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is 武田薬品工業株式会社 (Japan), which is also its direct parent. That group has 11 subsidiaries with LEIs in 9 countries, 2 of them in the United States. The LEI was first issued on 12 Nov 2016 and the record was last updated on 14 Sep 2023. It has lapsed: renewal was due by 13 Sep 2023. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 13 Sep 2023 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Mar 2022, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 14 Sep 2023.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 2894153 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 WILMINGTON, United States |
| Headquarters address | 1 Takeda Parkway, 60015 Deerfield, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 26 May 1998 |
| LEI | 549300W0D7WG0MRLHP67 |
| LEI status | lapsed |
| LEI first issued | 12 Nov 2016 |
| LEI record last updated | 14 Sep 2023 |
| Next LEI renewal | 13 Sep 2023 |
| Corroboration of the LEI record | fully corroborated |
Group membership
TAKEDA PHARMACEUTICALS U.S.A., INC. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | 武田薬品工業株式会社 | 武田薬品工業株式会社 |
| Accounting period | 1 Jan 2021 to 31 Dec 2021 | 1 Apr 2021 to 31 Mar 2022 |
| Evidence | supporting documents | consolidated accounts |
| Corroboration | supplied by the entity only | fully corroborated |
| Accounting standard | – | IFRS |
| Relationship start | 2 Oct 2017 | 2 Oct 2017 |
| Recorded at GLEIF since | 12 Nov 2016 | 12 Nov 2016 |
| Last updated | 14 Sep 2023 | 14 Sep 2023 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (7)
- TAKEDA U.S. FINANCING, INC. United States
- Baxalta Innovations GmbH Austria
- BioLife Plazma Hungary Korlátolt Felelősségű Társaság Hungary
- TAKEDA BELGIUM Belgium lapsed
- Takeda Manufacturing Austria AG Austria
- Takeda Pharmaceuticals Czech Republic s.r.o Czechia
- Takeda Pharmaceuticals International AG Switzerland
Other names
- Takeda Pharmaceuticals North America, Inc. · previous name